🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine time-to-progression (TTP) for an escalating dose schedule for sub...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2007-12
Trial ID
NCT00854620
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Royal Bournemouth Hospital
Start Date
2007-06
Trial ID
NCT00492258
Treatments Being Tested
These laboratory trial studies the development and treatment of a mouse mod...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-05
Trial ID
NCT01576185
Treatments Being Tested
This phase II trial studies how well sorafenib tosylate works in treating p...
Status
Completed
Location
Washington University School of Medicine
Start Date
2006-11-03
Trial ID
NCT00390325
Treatments Being Tested
This phase I trial studies the side effects and best dose of Chinese herbal...
Status
Completed
Location
City of Hope Medical Center
Start Date
2014-06-11
Trial ID
NCT01666756
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
Tom Baker Cancer Centre - Calgary
Start Date
2004-08-10
Trial ID
NCT00093457
Treatments Being Tested
This phase I trial is studying the side effects and best dose of sorafenib ...
Status
Completed
Location
Cancer and Leukemia Group B (CALGB) Research Base
Start Date
2004-10
Trial ID
NCT00118170
Treatments Being Tested
RATIONALE: Sorafenib and everolimus may stop the growth of cancer cells by ...
Status
Completed
Location
Holden Comprehensive Cancer Center at University of Iowa
Start Date
2007-08-29
Trial ID
NCT00474929
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2006-02
Trial ID
NCT00866320
Treatments Being Tested